These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3313407)

  • 1. Effects of prostacyclin analogues on platelet aggregation and blood pressure of anaesthetized beagle dogs.
    Hermán F; Hadházy P; Magyar K; Kovács G
    Prog Clin Biol Res; 1987; 242():101-6. PubMed ID: 3313407
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the disaggregating effect of prostacyclin (PGI2) in anaesthetized dogs.
    Hermán F; Hadházy P; Magyar K
    Biomed Biochim Acta; 1984; 43(8-9):S377-80. PubMed ID: 6393972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs.
    Hermán F; Magyar K; Chabrier PE; Braquet P; Filep J
    Br J Pharmacol; 1989 Sep; 98(1):38-40. PubMed ID: 2508983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of prostacyclin (PGI2) and acetate infusions on blood pressure.
    Ward RA; Williams TE; Harding GB
    Trans Am Soc Artif Intern Organs; 1983; 29():33-7. PubMed ID: 6369726
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 13. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

  • 15. 11- and 15-deoxy-carboprostacyclins: hypothetic prostacyclin antagonists.
    Mongelli N; Magni O; Gandolfi C; Grossoni M; Ceserani R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():281-5. PubMed ID: 6221538
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostacyclin derivatives on platelet factor 3 availability.
    Skopál J; Kovács M; Stadler I; Galambos G; Kovács G
    Thromb Res; 1987 Jul; 47(1):117-21. PubMed ID: 3310323
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A; Davì G; Novo S; Custro N; Mattina A; Gallo V
    Int Angiol; 1985; 4(3):379-82. PubMed ID: 3913716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.